E-LIB Suche - Ergebnisse für: Avery, Lindsay

1

1643. Pharmacodynamics (PD) of Daptomycin (DAP) in Combinat..:

Avery, Lindsay ; Kuti, Joseph L ; Weisser, Maja...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S47-S47 , 2018

2

1336. Assessment of the In Vivo Efficacy of WCK 5222 (Cefep..:

Abuhussain, Safa Almarzoky ; Avery, Lindsay ; Abdelraouf, Kamilia.
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S408-S408 , 2018

Link: https://doi.org/10.1093/..

3

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome. , 2024

Link: https://doi.org/10.36903..

4

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome. , 2024

Link: https://doi.org/10.36903..

5

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome. , 2024

Link: https://doi.org/10.36903..

6

A minimal physiologically based pharmacokinetic model to st..:

Patidar, Krutika ; Pillai, Nikhil ; Dhakal, Saroj..
Journal of Pharmacokinetics and Pharmacodynamics. , 2024

Link: https://doi.org/10.1007/..

7

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome. , 2024

Link: https://doi.org/10.36903..

8

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome. , 2024

Link: https://doi.org/10.36903..

9

Reproducibility Study on a PBPK Model of FcRn-Mediated Recy..:

Sargentini-Maier, Maria Laura ; Van Bogaert, Tom ; Avery, Lindsay B....
Physiome. , 2024

Link: https://doi.org/10.36903..

10

Mechanistic incorporation of FcRn binding in plasma and end..:

de Witte, Wilhelmus E. A. ; Avery, Lindsay B. ; Mackness, Brian C....
Journal of Pharmacokinetics and Pharmacodynamics. 50 (2023) 3 - p. 229-241 , 2023

Link: https://doi.org/10.1007/..

11

In vivo pharmacokinetics and pharmacodynamics of ceftibuten..:

Fratoni, Andrew J ; Avery, Lindsay M ; Nicolau, David P.
Journal of Antimicrobial Chemotherapy. 78 (2022) 1 - p. 93-100 , 2022

Link: https://doi.org/10.1093/..

12

590. Activities of Cefepime-Taniborbactam and Ceftazidime-A..:

Avery, Lindsay M ; Avery, Lindsay M ; Edwards, Mitchell...
Open Forum Infectious Diseases. 9 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

13

Evaluation of the in vitro activity of WCK 5222 (cefepime/z..:

Avery, Lindsay M. ; Mullane, Elias M. ; Nicolau, David P.
International Journal of Antimicrobial Agents. 55 (2020) 2 - p. 105863 , 2020

Link: https://doi.org/10.1016/..

14

1263. Assessment of Cefepime (FEP)-Taniborbactam (TAN) Huma..:

Avery, Lindsay M ; Vernacchio, Salvador ; McLaughlin, Lisa...
Open Forum Infectious Diseases. 7 (2020) Supplement_1 - p. S648-S648 , 2020

Link: https://doi.org/10.1093/..

15

Impact of a co-curricular, e-learning activity on pharmacy ..:

Drayton, Shannon J. ; Weeda, Erin R. ; Avery, Lindsay M...
Currents in Pharmacy Teaching and Learning. 11 (2019) 1 - p. 87-93 , 2019

Link: https://doi.org/10.1016/..